Skip to main content

Table 1 Overlap between GWAS reported genes and drug targets

From: GWAS and drug targets

Disease

Number of Drugs

GWAS reported genes

Number of drug targets

GWAS overlap, same disease*

GWAS overlap, all diseases**

Acute lymphoblastic leukemia

6

19

10

0

3

Age-related macular degeneration

9

23

2

1

2

Allergic rhinitis

69

11

20

0

5

Alzheimer's disease

5

54

179

0

40

Amyotrophic lateral sclerosis

3

26

2

0

1

Ankylosing spondylitis

39

17

29

0

9

Arthritis

168

7

112

0

35

Asthma

102

43

52

1

19

Atopic dermatitis

12

8

3

0

1

Atrial fibrillation

45

7

25

0

14

Attention deficit hyperactivity disorder

3

81

1

0

1

Autism

3

6

10

0

5

Basal cell carcinoma

6

8

9

0

2

Bipolar disorder/Schizophrenia

93

215

110

1

32

Blood pressure/Hypertension

351

100

114

3

35

Breast cancer

84

42

43

1

13

Celiac disease

3

74

1

0

0

Chronic kidney disease

8

69

6

0

2

Chronic lymphocytic leukemia

14

17

29

0

5

Chronic myeloid leukemia

6

9

15

0

6

Chronic obstructive pulmonary disease

14

18

7

0

2

Colorectal cancer

8

14

16

0

6

Coronary heart disease

6

84

5

0

3

Crohn's disease

7

136

23

0

9

Cystic fibrosis

8

7

11

0

5

Depression/Depressive disorder

45

68

73

0

17

Diabetes

46

205

59

4

21

Duodenal ulcer

8

2

18

0

5

Emphysema

10

5

17

0

5

Endometrial cancer

1

2

2

0

0

Endometriosis

5

4

7

0

3

End-stage renal disease

2

2

8

0

3

Epilepsy

18

1

53

0

10

Esophageal cancer

1

18

2

0

1

Gallstones

1

1

1

0

0

Gastric cancer

2

3

1

0

0

Glaucoma

24

13

31

0

6

Glioblastoma

2

1

1

0

0

Heart failure

51

16

65

0

27

HIV/AIDS

54

62

53

1

9

Hodgkin's lymphoma

8

7

31

0

7

Hypertriglyceridemia

2

5

4

0

3

Hypothyroidism

5

43

8

1

5

Inflammatory bowel disease

2

18

8

0

4

Kawasaki disease

1

20

11

1

5

Malaria

17

3

17

0

4

Male infertility

6

5

3

0

3

Melanoma

9

20

6

0

0

Menopause age

9

23

15

0

4

Migraine

20

7

46

0

10

Multiple myeloma

7

3

10

0

3

Multiple sclerosis

10

123

30

1

12

Myocardial infarction

29

14

44

0

17

Narcolepsy

2

4

6

0

1

Nephropathy/Nephrotic syndrome

20

26

38

0

9

Neuroblastoma

2

2

6

0

2

Non-small cell lung cancer

5

7

10

0

1

Obesity

4

40

11

0

4

Osteoarthritis

26

3

46

0

10

Osteoporosis

13

10

10

0

2

Ovarian cancer

5

10

4

0

1

Paget's disease

4

9

6

0

1

Pancreatic cancer

2

29

11

0

4

Panic disorder

6

10

18

0

4

Parkinson's disease

20

62

184

1

34

Polycystic ovary syndrome

2

7

2

0

1

Prostate cancer

14

94

21

0

8

Psoriasis/Psoriatic arthritis

19

30

39

0

13

Refractive error

1

4

4

0

1

Restless legs syndrome

2

6

18

0

6

Rheumatoid arthritis

46

67

80

2

29

Sleepiness

1

2

2

0

0

Stevens-Johnson syndrome/toxic epidermal necrolysis

1

12

1

0

0

Stroke

8

4

7

0

6

Tardive dyskinesia

3

1

22

0

7

Testicular cancer

4

7

6

0

2

Thyroid cancer

2

5

3

0

2

Tuberculosis

12

5

18

0

4

Type 1 diabetes

8

74

18

0

8

Type 2 diabetes

28

91

34

3

13

Ulcerative colitis

5

95

9

1

6

Uterine fibroids

1

7

1

0

0

Venous thromboembolism

1

7

3

0

2

Vitiligo

4

25

8

1

2

Mean

19.90

29.18

24.00

0.26

7.09

  1. *For each disease, the number of GWAS reported genes that are also drug targets for the disease.
  2. **For each disease, the number of GWAS reported genes that are drug targets for any disease.